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Glomerulonephritis in chronic lymphocytic leukemia and related B-cell
lymphomas. We retrospectively analyzed clinical presentation, immu-
nopathological data and renal outcome in 13 patients with glomerulo-
nephritis (UN) and chronic lymphocytic leukemia (CLL) or related
diffuse well-differentiated lymphocytic lymphoma (WDLL) of B-cell
lineage. B-cell proliferation and glomerulopathy were simultaneously
diagnosed in seven of the 13 patients. Nephrotic syndrome was ob-
served in nine patients. Serum creatinine was elevated (>120 tmol/
liter) in 10 patients and exceeded 400 mol/1iter in three patients. A clear
cut relationship between GN and hematologic disease could be estab-
lished in nine cases: five patients had MPGN caused by type I or type
II cryoglobulinemia; two had MPGN or mesangial hypertrophy with
circulating and deposited noncryoprecipitating monoclonal IgG K and
1gM K, respectively; in the two remaining patients, monotypic IgG K
glomerular deposits exhibiting fibrillary organization were observed in
association with MGN or MPGN, despite the absence of circulating
M-component by immunofixation. The pathophysiologic link between
glomerular lesions and B-cell proliferation was further evidenced by
effectiveness of specific treatment of the malignancy by chlorambucil.
This drug, used in the absence of steroids, induced complete remission
of nephrotic syndrome in the five patients to whom it was given.
Moreover, in the five patients with creatininemia >200 mol/liter who
received chemotherapy, substantial improvement in renal function was
observed. These overall data demonstrate that the occurrence of UN in
B-CLL and related lymphoma is not fortuitous, and testify to the
paraneoplastic nature of glomerular involvement mediated by deposi-
tion and possibly processing of cryoprecipitating or noncryoprecipitat-
ing M-components.
The occurrence of glomerular lesions is well-established in
plasma cell dyscrasias (PCD) characterized by proliferation of a
single clone of B cells, usually plasma cells, that secrete a
homogeneous monoclonal M-protein (light chain or complete
immunoglobulin molecule) [1]. They include AL-amyloidosis,
light-chain (and sometimes, heavy chain) deposit disease (also
referred to as monoclonal immunoglobulin deposition disease
[2]), cryoglobulinemia and 1gM thrombi in Waldenström's mac-
roglobulinemia [3]. In all cases, glomerular involvement is
clearly related to secretion followed by glomerular deposition
and eventually local processing of the M-component. In con-
trast, in the subset of PCD (chronic lymphocytic leukemias,
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B-cell lymphomas) in which proliferation of the B-cell clone
does not lead to plasma-cell terminal differentiation, incidence
of glomerulonephritis (GN) seems to be considerably lower and
the physiopathologic links with the hematologic malignancy
appear most often hypothetical. This applies to chronic lym-
phocytic leukemia (CLL) in which (i) the association of glomer-
ular disease is apparently extremely rare (29 cases reported in
the literature [4—24]) despite the relative frequency of this type
of leukemia [25]; (ii) the spectrum of glomerular lesions seems
wide, including type I and type II membranoproliferative gb-
merulonephritis (MPGN), focal proliferative GN, membranous
GN, minimal change disease and amyloidosis [4—24]. This could
suggest that the association between GN and CLL might be
fortuitous.
We investigated a retrospective study of 11 patients with
CLL and two additional patients with related diffuse, well-
differentiated lymphocytic lymphoma (WDLL) of B-cell lin-
eage. In nine of 13 patients, a clear cut relationship between
B-cell proliferation and GN could be established in the form of
cryoglobulinemia responsible for MPGN (5 cases) or, more
interestingly, of monoclonal-component glomerular deposits
without cryoglobulinemia (4 cases). In two of the latter cases,
monotypic IgG K deposits were detected in the absence of
circulating M-component and were associated with fibrillary
organization. In addition, this study also shows that treatment
of the B-cell proliferation could induce regression of nephrotic
syndrome and/or renal insufficiency in nine of ten patients.
Methods
Selection of patients
Eleven patients with CLL and two patients with WDLL were
included in this study. All had symptoms of GN and underwent
a renal biopsy. Diagnosis of CLL relied on sustained lympho-
cytosis >5 X 109/liter and bone marrow infiltration (>30%
lymphocytes) by predominantly mature lymphocytes. Clinical
staging was carried out according to Binet's classification [25].
Briefly, stages A and B are defined by sustained lymphocytosis
and the number of areas of lymphoid involvement (less than 3 in
stage A and 3 or more in stage B); stage C is characterized by
anemia (hemoglobin <10 g/dl) or thrombocytopenia (platelet
count <10 x l09/liter) regardless of the number of areas of
lymphoid involvement. Diagnosis of WDLL relied on predom-
inant involvement of lymph nodes in which characteristic
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Table 1. Clinical and laboratory features of patients at the time of renal biopsy
Bone marrow
Prior duration examination and
of LPD lymph node biopsyAge/sex
1 M/41 2 years 62% L + LI B 200 NS Gross Arthralgia
2 M/60 S 55% L C 150 2 g/day ++ Raynaud's phenomenon, vascular
purpura, arthralgia
3 M/74 S WDLL (Node biopsy) — 600 1 g/day Gross Cutaneous vasculitis
4 Ff63 3 years 71% + LI B 500 NS ++ Cutaneous vasculitis, diabetes
5 M/71 8 years 65% L B 70 NS
6 Mf58 5 years LI B 150 NS + + AITP
7 Ff57 3 years LI C 70 3 gfday + AIHA
8 M/76 S 77% L
WDLL (Node biopsy)
— 105 NS + AIHA
9 M/55 S 64% L + LI C 150 NS +
10 Ff67 S 76% L B 300 NS + Gastric cancer 9 years before
11 Ff77 3 years LI C 320 0.6 gfday ++
12 Ff81 S 88%L A 160 NS ++
13 Mf68 5 77% L C 450 NS Gross Sepsis
Abbreviations are: prior duration of LPD, apparent duration (years) of the lymphoproliferative disorder before diagnosis of glomerular disease;
S, simultaneous diagnosis; bone marrow examination, % of mature lymphocytes at bone marrow aspiration; LI, lymphocytic infiltration; WDLL,
well-differentiated lymphocytic lymphoma; stage, Binet's classification (see text); renal presentation, NS = nephrotic syndrome; Sr, serum
creatinine; AIHA, autoimmune hemolytic anemia; AITP, autoimmune thrombocytopenia.
features of WDLL could be identified. The B-cell origin of the
lymphoma was proven by the presence of monotypic I5G K
glomerular deposits in one case, and a type II IgG-IgA cryo-
globulinemia in the other case. We excluded from this study
patients with Waldenström's macroglobulinemia characterized
by substantial plasma cell differentiation of the B-cell clone
leading to the production of >5 gfliter monoclonal 1gM. The
search for a circulating M-component (by immunoelectrophore-
sis and immunofixation in the most recent observations), and
for cryoglobulinemia and signs of complement consumption
was systematically carried out.
Pathology
Renal biopsies were examined by light microscopy, immuno-
fluorescence (IF) and, in two cases, electron microscopy.
Material for light microscopy was fixed in Duboscq-Brasil
fixative and processed by standard histologic techniques. Stain-
ings currently used in our laboratory include: hematoxylin and
eosin, Masson's trichrome, periodic acid-Schiff and silver
methenamine. In addition, sections were systematically stained
with Congo red and examined under polarized light. IF studies
were performed in 12 cases by incubating cryostat sections with
fluorescein isothiocyanate-conjugated antisera specific for hu-
man IgG, IgA, 1gM, Clq, C3 and fibrinogen (Hoechst-Behring,
Rueil-Malmaison, France); six biopsies were further examined
with antisera to human kappa- and lambda-light chains (Atlantic
antibodies, Orimbio, Paris, France). Finally, two biopsies were
studied by electron microscopy. For this purpose, tissues were
fixed in 2.5% glutaraldehyde in 0.2 M sodium cacodylate buffer
at pH 7.2, then post-fixed in osmium tetroxide. Sections were
stained with uranyl acetate and lead citrate and viewed in an
EM 109 Zeiss electron microscope.
Results
Hematologic and renal presentation of patients
Table I shows the clinical, hematologic and renal data in the
11 patients with CLL (pts 1, 2, 4—7, 9—13) and the two others
with WDLL (pts 3 and 8). There were eight males and five
females, with a mean age of 62.5 years (range 41 to 81). B-cell
proliferation and glomerulopathy were simultaneously diag-
nosed in seven of the 13 patients. In other cases, diagnosis of
hematologic disease had preceded the discovery of renal lesions
by two to eight years. All patients with CLL fuffilled the
classical diagnostic criteria. They all presented major lympho-
cytic infiltration in bone marrow estimated either by aspiration
(% mature lymphocytes is then given) or by biopsy, usually
associated with lymphoid organ involvement. According to
Binet's classification, one was stage A, five were stage B and
five stage C. The two patients with WDLL had characteristic
lymph-node lesions associated in patient 8 with massive infil-
tration of the bone marrow and blood lymphocytosis (7 x
109/liter).
Proteinuria exceeded 2 glday in 11 patients and nephrotic
syndrome was the major heralding sign leading to discovery of
renal involvement in nine patients. Proteinuria was associated
with hematuria in 12 of 13 patients. The latter reached a
macroscopic level in three cases. Renal lesions were also
responsible for renal failure in 10 patients (as defined by
creatininemia >120 mol/liter); three of these patients (3, 4 and
13) exhibited severe renal insufficiency, with serum creatinine
>400 mol/liter.
Moreover, four patients (1, 2, 3 and 4) presented symptoms
compatible with cryoglobulinemia, including Raynaud's syn-
drome, arthralgias, purpura and other manifestations of cuta-
neous vasculitis. Auto-immune hemolytic anemia or thrombo-
cytopenia were noted in three cases. Only two patients (7 and
11) had been intermittently treated with low dose chlorambudil
before appearance of renal symptoms.
Immunologic and pathologic data
Ten of 13 pttients showed evidence of production of a
M-component 13y the B-cell proliferating clone (Table 2): four
had a type I (IgG K, pt. 4) or type II (IgM-IgG, pts 1 and 2;
Case
no.
Renal presentation
5Cr
Stage j.molf liter Proteinuria Hematuria
Associated manifestations and
diseases
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Table 2. Immunologic data and renal pathology
Case
Glomerular lesions Interstitial
lymphocyticLight Electron
no. Dysproteinemia C' microscopy Immunofluorescence microscopy Vascular lesions infiltrates
1 Cryo IgG-IgM CH50 MPGN IgG, 1gM, C3
subendothelial + thrombi
2 Cryo IgG-IgM CH50—* MPGN IgG, 1gM, C3, K, A
subendothelial + thrombi
3 Cryo IgG-IgA CH50— MPGN IgG, C3 mesangial and
subendothelial
Arteriolar inflammatory
infiltrate without
deposit
4 Cryo IgGK CH30 j, C3—, C4 MPGN C3 mesangial +
5 Cryo+ (NA) CH50 , C3—*, C4 MPGN IgG, C3 subendothelial +
thrombi, 1gM mesangial
6 IgG,, CH50—, C3— MPGN IgG, C3, K subendothelial
+ thrombi
Small arteries: intimal K
deposits and fibrinoid
necrosis
++
7 1gM,, CH50 ., C3 ,, C4 Mesangial
hypertrophy
1gM and K mesangial +
8 0 CH50 , C3 ,, C4 MPGN IgG, C3, K subendothelial Fibrillary
deposits
+
9 0 CH50 MGN IgG, C3, K subepithelial Fibrillary
deposits
Small arteries: intimal K
deposits
++
10 IgG,, CH50—, C3— MPGN ND ++
11 IgG,, CH50—, C3 , C4— FSGN 1gM, C3 mesangial
12 0 CH50—÷ Advanced
sclerosing GN
C3 segmental or global
13 0 CH50 f Crescentic
GN
ND
Abbreviations are: Dysproteinemia, cryoglobulinemia or M-component; 0, not detected; +(NA), present but not analyzed; C', complement
components; —*, normal; , reduced; , increased; light microscopy: MPGN, membranoproliferative glomerulonephntis; MGN, membranous
glomerulonephritis; FSGN focal segmental glomerulonephritis; ND, immunofluorescence not determined. Interstitial tumoral lymphocytic
infiltrates were graded according to cell density.
IgG-IgA, pt. 3) cryoglobulinemia; four had a non-cryoprecipi-
tating IgG K (pts 6, 10 and 11) or 1gM K (pt. 7); and two had
monotypic IgG K deposits in the renal biopsy in the absence of
circulating M-component even by immunofixation (pts 8 and 9).
Interestingly, when identified, the light chain was always of the
K type (pts 4, 6, 7, 8, 9, 10 and 11). The high percentage of
M-component in blood and/or in renal biopsy (76.9%) sharply
contrasted with the low incidence (5 to 10%) usually reported in
series of CLL and WDLL. Moreover, signs of complement
consumption were detected in seven patients, either in associ-
ation with a cryoglobulinemia (pts 1, 4 and 5) or in the presence
of a non-cryoprecipitating M-component (pts 7 and 11), or even
in the absence of any circulating M-component (pts 8 and 9).
MPGN was by far the most frequent type of GN encountered
in these patients since it was observed in eight of them (Table
2). Lesions of MPGN were typically endocapillary proliferation
with capillary wall lesions, including subendothelial deposits
and a double contour aspect. In some cases (pts 3, 4, 5),
glomerular lesions were focal and segmental with less promi-
nent subendothelial deposits and scarce well-developed double
contours, Some segmental crescents were seen in biopsies from
patients 3, 6 and 10, but extracapillary proliferation was never
a prominent feature. In five patients (1 to 5), MPGN was
associated with cryoglobulinemia and components of the cry-
oglobulin could be detected in glomeruli from patients 1 and 2.
In patient 3, only IgG was present in glomeruli together with C3
whereas IgA, the second constituent of the cryoglobulin, was
undetectable. In patient 5 whose cryoglobulin could not be
analyzed, the presence of IgG and 1gM deposits in glomeruli
suggested that it was made of these two Ig types. Intraluminal
thrombi suggestive of cryoglobulin deposition were also ob-
served by IF in three biopsies (1, 2, 5). In patient 3, light
microscopy showed coagula in some capillary lumens with focal
polymorphonuclear infiltration of the capillary tufts. Two addi-
tional patients (6 and 10) had a membranoproliferative type
glomerulonephritis associated with a noncryoprecipitating
monoclonal IgG K. Subendothelial monotypic IgG K deposits
and thrombi were detected in glomeruli of patient 6, whereas IF
study could not be performed in patient 10 because the frozen
sample only contained medulla. Finally, in patient 8 who had
typical MPGN by light microscopy (Fig. 1), exclusive suben-
dothelial IgG K deposits were also observed (Fig. 2 a,b)
together with signs of complement consumption through acti-
vation of the classical pathway, but in the absence of circulating
M-component and cryoglobulinemia. Electron microscopy ex-
amination (Fig. 3 a,b) identified irregular subendothelial depos-
its together with mesangial interposition and focal effacement of
foot processes of the epithelial cells, and on higher magnifica-
tion, disclosed fibrillary organization of the deposits. The
microfibrils were loosely packed, irregularly bent and haphaz-
ardly arranged; their diameter was 8 nm. This biopsy, as the
others, was negative for Congo red staining and birefringence.
The five remaining patients exhibited various types of gb-
merular lesions (Table 2). The biopsy of patient 7 showed
increase in mesangial matrix and monotypic deposits of z heavy
chain and K light chain localized in the mesangium and associ-
ated with a circulating 1gM K M-component. Patient 9 had an
atypical form of MGN with foci of mesangial hypertrophy and
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Fig. 1. Light microscopy. Case 8.
Membranoproliferative type
glomerulonephritis. Note mild cellular
proliferation, mesangial and subendothelial
deposits, double contour appearance (arrow).
Masson's trichrome stain. Original
magnification x 312.
cellular proliferation (Fig. 4), and exclusive IgO K epimembra-
nous deposits (Fig. 2 c,d) despite the lack of circulating lgG K
by immunoelectrophoresis and immunofixation. By electron
microscopy, these deposits had a fibrillary structure (Fig. 3
c,d). They consisted of microtubules with a diameter of 22 nm.
There were no deposits in extraglomerular location. Mesangial
interposition was seen in rare lobules. In the two latter cases,
signs of complement activation were also observed. Patient 11
had a focal and segmental form of proliferative ON with
mesangial C3 deposits as well as a circulating monoclonal IgG
K with decreased C3, but the M-component could not be
detected in glomerular lesions. Patient 12 had advanced scie-
rosing ON with nonspecific segmental or global C3 deposits.
Finally, patient 13 developed extracapillary proliferative ON in
the setting of severe infectious complications of CLL; no
sample was available for IF microscopy.
In addition to glomerular lesions, vasculitis was detected in
renal biopsies of three patients by light microscopy and/or
immunofluorescence. In patient 3 who had exsudative glomer-
ular lesions, a small perivascular granuloma was found in the
wall of an arteriole, in the absence of necrosis and abnormal
deposit. Intimal K light chain deposits were present in several
small arteries in patient 9 who had monotypic IgO K subepi-
thelial deposits. Vascular lesions were more prominent in
patient 6: small arteries exhibited heavy intimal deposits and
fibrinoid necrosis irregularly spread in the adventice of the
vessel (Fig. 5); K vascular deposits were detected by immuno-
fluorescence, as well as IgG K in glomeruli. Finally, interstitial
tumoral lymphocytic infiltration was observed in patients 4, 6,
7, 8, 9 and 10.
Clinical course and effect of treatment
Ten patients (8 with CLL and 2 with WDLL) were given
chemotherapy based on oral chiorambucil in seven cases (Table
3). Among the seven treated patients with nephrotic syndrome,
complete remission was achieved in six, and partial remission
(proteinuria <3 g/day) was obtained in one. Interestingly,
chlorambucil induced complete remission of nephrotic syn-
drome in all five patients to whom it was given alone, in the
absence of steroids. In the eight patients with renal failure
(creatininemia >120 smol/liter) in whom serum creatinine was
monitored, renal function improved in seven and worsened in
the only one who did not receive chemotherapy. Particularly
impressive in this respect were the observation of patient 4
(initial creatininemia = 500 mol/liter) in whom chlorambudil
induced reduction by more than half of serum creatinine, and
patient 10 (initial creatininemia 300 mol/liter) in whom
chlorambucil treatment was associated with subcomplete re-
covery of renal function, although both were affected with
severe MPGN. Benefits of treatment were also substantial in
patient 6 who underwent a second renal biopsy one year after
initiation of chlorambucil. The latter showed decreased mesan-
gial hypercellularity and rarefaction of double contour aspects
together with complete disappearance of glomerular thrombi,
angeitis and lymphocytic infiltrates; in contrast, progression of
glomerular and tubulointerstitial sclerosis was moderate. The
improvement in renal parameters was always associated with
concurrent regression of lymphadenopathies and lymphocyto-
sis.
Discussion
Despite multiple potential causes of renal complications,
including occasional production of monoclonal immunoglob-
ulins, frequent infections due to decreased immune response
and T cell dysregulation and possible occurrence of epithelial
tumors [261, ON has been exceptionally reported in the litera-
ture in patients with CLL. Twenty-nine cases of such associa-
tion have most often been reported as single cases [4—24]. As in
our series, the glomerulopathy often revealed CLL, and in 13 of
27 cases, the diagnoses were made simultaneously. The ne-
phrotic syndrome was present in most cases (26 of 29), and
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Fig. 2. Immunofluorescence microscopy. Case 8. Massive subendothelial and mesangial deposits of IgG (a) and kappa light chain (b). No staining
was observed for lambda light chains. Original magnification x400. Case 9. Diffuse granular deposits along the capillary walls with predominant
subepithelial localization. Staining was exclusive for IgG (c) and kappa light chain (d). Original magnification X 312.
associated with renal insufficiency in one third of the observa-
tions. The profile of glomerular lesions reported in the literature
is close to that of our series, with a prevailing incidence of
MPGN (8 type I and 1 type II MPGN) [7, 9, 12, 13, 16, 21, 241.
MON was reported in five patients [10, 18, 22, 24], The
remaining observations were heterogeneous, including minimal
glomerular changes, focal segmental sclerosis and focal glomer-
ulosclerosis [4, 6, 8, 14, 15, 21, 23], unclassified proliferative
glomerulopathy [9, 10, 14, 21], amyloidosis [4, 5] and one case
of immunotactoid glomerulonephritis [20]. Both the heteroge-
neity and the rarity of glomerular involvement previously
reported in CLL led us to study the relationship between
occurrence of glomerular disease and the hematologic malig-
nancy. For this purpose, we carefully searched for the presence
of circulating M-component and evidence of its deposition in
glomeruli.
In nine cases (pts 1 to 9), it was possible to establish a clear
cut relationship between ON and CLL. They first include five
patients with MPGN caused by cryoglobulinemia (1 type I and
4 type II). The existence of type I or type II cryoglobulinemia is
not surprising in a lymphoproliferative disorder such as B-CLL,
where the B-lymphocyte clone can be secretory. From a
physiopathologic point of view, cryoglobulins can be, on the
one hand, considered as immune complexes in which the
antigen is a polyclonal immunoglobulin (type II or type III
cryoglobulin) or remains of undetermined nature (type I cry-
oglobulin). In the case of type II and type III cryoglobulins, the
polyclonal immunoglobulin itself is endowed with antibody
activity that is most often not identified. Gilboa et al [12] made
an interesting observation in two patients with CLL associated
with type I MPGN, hypocomplementemia and type I cryoglob-
ulinemia composed of an IgG K M-component. They detected
cryoglobulin components in the kidneys and showed that Ig
eluted from both the glomeruli and the serum cryoglobulin
bound in vitro to patients' glomeruli but not to normal glomer-
uli, thereby suggesting that the monoclonal IgG K was directed
to nonglomerular antigens. The latter might be lymphocyte
antigens as suggested by Day et al [26] or nonlymphocyte
antigens including viral antigens. In this respect, Sutherland
and Mardiney [27] identified immune complex deposits contain-
ing an oncornavirus-related antigen in glomeruli of patients
suffering from leukemia or lymphoma; however, since this
observation was made in the absence of clinical symptoms, the
'1
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Fig. 3. Electron microscopy. Case 8. (a.) Irregular thickening of the capillary walls with subendothelial deposits. Endo = endothelial cell; epi =
epithelial cell. Uranyl acetate and lead citrate. Original magnification x2,950. (b.) On high magnification, the deposits are organized in a fine fibrillar
structure. Original magnification x 15,500. Case 9. (C.) Electron micrograph of a glomerular capillary; subepithelial deposits of fibrillar material. L
= capillary lumen; R = red blood cell. Uranyl acetate and lead citrate. Original magnification x4,400, (d.) Higher magnification of the capillary
wall showing fibrillar structures cut at various angles. Original magnification X 12,000.
pathogenic effect of these immune complexes remains hypo-
thetical. On the other hand, because of cryoglobulin ability to
precipitate in vessels under certain circumstances, a direct
pathogenic role, that is, one nonmediated by immune com-
plexes, should be suspected in forms of MPGN with intracap-
illary thrombi and fibrillary organization of deposits by electron
microscopy. Whatever the mechanisms leading to cryoglobulin
deposition, macrophagic infiltration seems to be of utmost
pathogenic importance and may even precede the detection of
immune deposits as demonstrated in one observation of B
monoclonal small lymphocytic lymphoma with type II cryo-
globulinemia and GN reported by Jacquot et al [28].
Second, in four of the nine patients, monotypic Ig deposits
were found in glomeruli in the absence of cryoglobulinemia. In
the first two patients of this subgroup (6 and 7), deposits were
associated with a circulating M-component. Even more inter-
esting, in patients 8 and 9, the circulating M-component could
not be detected despite the use of sensitive techniques including
immunofixation. In three of these four cases, the monoclonal Ig
induced complement activation. These observations suggest
that in B-CLL as well as in related lymphomas (pt. 8), the
secreted M-component can injure glomeruli through noncryo-
globulin-mediated mechanisms. On the one hand, lesions of
mesangial hypertrophy observed in patient 7 might be the first
step in the development of monoclonal immunoglobulin depo-
sition disease. Similar cases have been reported in the litera-
ture, but earlier observations are dillicult to interpret in the
absence of studies with light-chain specific antisera. Brodowsky
et a! [61 reported focal glomerulosclerosis in a patient excreting
kappa Bence Jones proteinuria. Seney et al [21] suggested the
possibility of monoclonal immunoglobulin deposition disease in
one of his patients, who had a circulating monoclonal IgG
lambda with lambda Bence Jones proteinuria and nodular
glomeruloscierosis; by immunoperoxidase analysis, the mesan-
gial nodules were exclusively stained by the anti-lambda light
chain antibodies. On the other hand, our observations 8 and 9
are quite different and cannot be ascribed to monoclonal
immunoglobulin deposition disease because of the fibrillary
aspect of glomerular deposits by electron microscopy and the
absence of deposits along tubular basement membranes. They
recall two patients with B-CLL and atypical MON reported by
Touchard et al [241, who demonstrated exclusive subepithelial
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Fig. 4. Light microscopy. Case 9. Atypical
membranous glomerulonephritis: in addition
to the irregular aspect of the capillary walls,
note segmental mesangial hypertrophy and
cellular proliferation. Silver stain. Original
magnification x 312.
Fig. 5. Light microscopy. Case 6. Note heavy
arteriolar intimal deposits and fibrinoid
necrosis in the perivascular space (arrow).
Hematoxylin and eosin. Original magnification
x312.
IgG K deposits despite the absence of circulating M-component
searched for by immunofixation technique. At the ultrastruc-
tural level, glomeruli contained organized microtubular struc-
tures that were also found in the cytoplasm of circulating
lymphocytes, thus suggesting yet undefined physicochemical
anomalies of the M-component leading to rapid deposition (and
processing?). A similar observation of atypical membranous
GN with fibrillary subepithelial deposits in a patient with
diffuse, small cleaved cells, intermediate grade lymphoma has
also been reported by Rosenmann et al [29]. These patients can
be classified in the heterogeneous group of fibrillary GN,
together with immunotactoid glomerulopathies. It must be
noted that one patient from the series of Korbet et al [20] had
immunotactoid glomerulopathy and CLL. Such observations of
B-CLL and related B-lymphomas, characterized by the pres-
ence of glomerular deposits of monoclonal Ig (or fragments
thereof), are of high pathophysiologic interest. (i) They estab-
lish a link, represented by the M-component, between lymphoid
proliferation and glomerular involvement. (ii) Forms without
detectable circulating Ig suggest the existence of peculiar anom-
alies of the secreted Ig (unusual sensitivity to proteolytic
enzymes, secretion in polymeric form, physicochemical anom-
alies) similar to those observed in monoclonal iminunoglobulin
deposition disease. (iii) The diversity of the glomerular lesions
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Table 3. Clinical course
Case
no. Follow-up
Treatment
Renal outcome
.Vital outcome at last
follow-up Cause of death
.
Nephrotic
syndrome Renal functionChemotherapy Steroids
I Yes CBL Yes CR Improveda Died (5 mo) Sepsis
2 No — NA NA Died (2 mo) Unknown
3 Yes MOPP Yes — Improved Died (4 yrs) Leukemia and sepsis
4 Yes CBL CR Improved Alive (2 yrs)
5 Yes CBL CR Stable
(normal)
Alive (8 yrs)
6 Yes CBL CR Improved Died (3 yrs) Colon cancer
7 Yes CBL NA NA Died (3 mo) Pulmonary sepsis
8 Yes CBL CR Stable
(normal)
Alive (2 yrs)
9 Yes CHOP/CBL Yes PR Improved Died (3 yrs) Sepsis
10 Yes CBL CR Improved Died (4 yrs) Unknown
11 Yes CP — Improved Alive (6 mo)
12 No No NA NA NA
13 Yes No Persistent Worsened Died (2 mo) Renal failure and septic
shock
Abbreviations are: CBL, chlorambucil; CHOP, cyclophosphamide, adriamycin, vincristine, prednisone; MOPP, nitrogen mustard, vincristine,
procarbazine, prednisone; CP, cyclophosphamide; PR, partial remission of nephrotic syndrome (daily proteinuria <3 g/24 hr); CR, complete
remission of nephrotic syndrome (daily proteinuria <I g/24 hr); improved, serum creatinine decreased by more than 50% from initial value. NA,
not available.
a Patient 1 relapsed with nephrotic syndrome and renal failure, again controlled by treatment.
observed enlarges the spectrum of glomerular diseases due to
plasma cell dyscrasias.
In contrast, in the four remaining patients, the link between
glomerular lesions and B-cell disease either cannot be estab-
lished for lack of sufficient immunopathological data or is more
tenuous but cannot be excluded. In patients 10 and 11 who had
MPGN and focal segmental proliferative GN, respectively, the
responsibility of the circulating IgG K cannot be demonstrated
because of the absence of glomeruli in the biopsy fragment
allotted to IF (pt. 10) and of M-component deposits in glomeruli
(pt. 11). In the last two patients (12 and 13), the physiopatho-
logic discussion is even more difficult in the absence of circu-
lating M-component: patient 12 had advanced glomerular le-
sions without monotypic deposits, and patient 13 had a
crescentic GN occurring at the same time as severe infection.
Besides its pathophysiologic interest, this series of GN in
CLL and related B-cell lymphomas suggests that severe cases
of proliferative GN with renal failure can be controlled, and
possibly cured by chemotherapy. Chlorambucil—a drug that is
rarely used in the treatment of proliferative GN—proved to be
extremely effective since it induced complete remission of
nephrotic syndrome in the five patients in whom it was used
alone and in the absence of steroids. Moreover, in all five
patients with creatininemia >200 jsmol/liter who were given
chemotherapy either by chlorambucil (pts 1, 4, 10), cyclophos-
phamide (pt. 11) or MOPP (pt. 3), substantial improvement in
renal function was obtained although four of these patients had
MPGN, a type of GN usually endowed with poor prognosis.
Parallel regression of lymphocytosis and lymphocyte infiltration
was observed. These data provide further indirect evidence of a
physiopathologic link between GN and hematologic disease,
and thus testify to the paraneoplastic nature of glomerular
involvement.
In conclusion, this study grounded on immunopathologic
analysis of GN in CLL and related B-cell lymphomas demon-
strates that the occurrence of GN in these hematologic malignan-
cies is not fortuitous but is mediated via secretion, deposition and
possibly processing of an M-component. This association thus
represents a particularly interesting model for analysis of the
pathophysiologic mechanisms involved in glomerular diseases.
In addition, the link that we have established is of both clinical
interest because the nephropathy can reveal the hemopathy or
accompany a relapse, and therapeutic interest because treat-
ment of the malignancy is also frequently effective toward the
glomerulopathy.
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